Notably, there was a higher abundance of tumor-promoting immune cells, such as Type 2 T helper cells, Myeloid-derived suppressor cells (MDSCs) and regulatory T cells, in the PLK1-high groups, which may be responsible for the worse prognosis. This evidence concerns the gene PLK1 and neoplasm.